Teleflex Incorporated $TFX Shares Sold by Lazard Asset Management LLC

Lazard Asset Management LLC cut its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 44.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,558 shares of the medical technology company’s stock after selling 28,760 shares during the period. Lazard Asset Management LLC’s holdings in Teleflex were worth $4,253,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Rice Hall James & Associates LLC grew its holdings in shares of Teleflex by 16.4% in the first quarter. Rice Hall James & Associates LLC now owns 4,721 shares of the medical technology company’s stock valued at $565,000 after purchasing an additional 664 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in Teleflex during the 1st quarter worth approximately $6,782,000. GC Wealth Management RIA LLC acquired a new stake in Teleflex during the 1st quarter worth approximately $1,492,000. Systematic Financial Management LP acquired a new stake in Teleflex during the 1st quarter worth approximately $1,922,000. Finally, PNC Financial Services Group Inc. boosted its position in Teleflex by 11.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 17,346 shares of the medical technology company’s stock valued at $2,075,000 after buying an additional 1,759 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Up 3.3%

Shares of Teleflex stock opened at $136.72 on Friday. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $139.67. The company has a market capitalization of $6.05 billion, a P/E ratio of -6.00, a P/E/G ratio of 0.98 and a beta of 0.82. The company has a 50 day moving average of $130.96 and a 200 day moving average of $121.37.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. During the same period in the prior year, the firm posted $1.44 EPS. The company’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.96%.

Analyst Upgrades and Downgrades

TFX has been the subject of several research reports. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $140.00 to $160.00 in a research note on Monday, June 8th. Wall Street Zen cut Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday. Needham & Company LLC lifted their target price on Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a report on Friday. Raymond James Financial reissued an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Finally, Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a report on Monday, April 13th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $148.90.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.